,i  #aag? ,,congress  #b;d ,session  ,h4
 ,r4 #icjc  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,novemb] #ae1         
#bjbb,mr4 ,lev9 ( ,cali=nia 7= himself &
 ,mr4 ,f]guson7 introduc$ ! foll[+ bill2
 :i* 0 ref]r$ to ! ,committee on ,=eign 
,affairs  ,a ,,bill  ,to direct !       
,secret>y ( ,heal? & ,human ,s]vices1 9 
consultation ) ! ,secret>y ( ,/ate1 to  
=mulate a /rategy = ! ,f$]al ,gov]nm5t  
to secure support f =eign c\ntries1     
multilat]al organizations1 & o!r        
appropriate entities to facilitate !    
developm5t & comm]cialization ( qualifi$
 p&emic or epidemic products1 & = o!r   
purposes4  #a4 ,%ort title ,?is ,act may
 be cit$ z ! ,sav+ ,u f ,p&emic ,era    
,resi/ance by ,build+ a ,unifi$ ,global 
,/rategy ,act ( #bjbb or ! ,,sup] ,,bugs
 ,act ( #bjbb4  #b4 ,int]national       
/rategy = developm5t ( qualifi$ p&emic  
or epidemic products  7a7 ,/rategy  7#a7
 ,9 g5]al ,n lat] ?an #ah mon?s aft] !  
date ( enactm5t ( ?is ,act1 ! ,secret>y 
( ,heal? & ,human ,s]vices1 9           

consultation ) ! ,secret>y ( ,/ate1     
%all--  7,a7 =mulate a /rategy = !      
,f$]al ,gov]nm5t to secure support f    
=eign c\ntries1 multilat]al             
organizations1 & o!r appropriate        
entities to facilitate ! developm5t &   
comm]cialization ( qualifi$ p&emic or   
epidemic products1 includ+ su* products 
to address antimicrobial resi/ant       
pa?og5s-- 7i7 ) p&emic pot5tial2 or     
7ii7 t are priority pa?og5s2 &  7,b7    
submit su* /rategy to ! appropriate     
committees ( ,congress4  7#b7 ,cont5ts  
,! /rategy "u p>agraph 7#a7 %all-- 7,a7 
provide = ! process ! ,f$]al ,gov]nm5t  
w\ld use to ent] into arrangem5ts )     
=eign c\ntries1 multilat]al             
organizations1 & o!r appropriate        
entities 9 c]ta9 circum/ances2  7,b7    
/rive to secure equitable contributions 
among p>ticipat+ c\ntries1              
organizations1 & entities2  7,c7 focus  
on global priorities b all[ p>ticipat+  
c\ntries1 organizations1 & entities to  
emphasize national or regional issues ( 

importance2  7,d7 seek to ensure su*    
arrangem5ts are h>moniz$ ) ea* o!r & )  
o!r relevant arrangem5ts to prev5t      
duplication ( ef=t & to effici5tly      
di/ribute funds2  7,e7 provide =        
collaboration s z to allocate jo9t or   
individual responsibility across        
p>ticipat+ c\ntries1 organizations1 &   
entities = ! developm5t &               
comm]cialization ( p>ticul> qualifi$    
p&emic or epidemic products1 :]e su*    
collaboration is spell$ out be=eh& 9 su*
 arrangem5ts2  7,f7 provide = ! /ew>d%ip
 ( qualifi$ p&emic or epidemic products 
develop$ pursuant to ! /rategy2  7,g7   
def9e crit]ia s t sc>ce funds are       
allocat$ to advance qualifi$ p&emic or  
epidemic products t c a*ieve ! greate/  
positive impact on human heal?1 includ+ 
unprec$5t$ approa*es to prev5t+1 treat+1
 & diagnos+ infecti\s diseases2  7,h7   
consid] approa*es includ+ secur+        
contracts ) ! private sector1 ent]+ into
 public-private p>tn]%ips1 implem5t+    
alt]native paym5t models1 & /reaml9+    

regulatory approval processes2 &  7,i7  
be syn*roniz$ ) ,unit$ ,/ates p&emic    
prep>$ness priorities1 su* z ! ,u4,s4   
,national ,action ,plan = ,combat+      
,antibiotic-,resi/ant ,bact]ia 7,,c>b74 
7b7 ,arrangem5ts ) =eign c\ntries &     
multilat]al organizations ,! ,secret>y (
 ,heal? & ,human ,s]vices1 9            
consultation ) ! ,secret>y ( ,/ate1 %all
 seek to ent] into arrangem5ts ) =eign  
c\ntries1 multilat]al organizations1 &  
o!r appropriate entities to implem5t !  
/rategy "u subsection 7a74  7c7         
,def9ition ,9 ?is section3  7#a7 ,! t]m 
priority pa?og5s means pa?og5s id5tifi$ 
9 ! late/ ,c5t]s = ,disease ,control &  
,prev5tion ,antimicrobial ,?reats       
,report1 ! ,_w ,heal? ,organization     
,global ,priority ,pa?og5s ,li/1 or a   
successor report or li/4  7#b7 ,! t]m   
qualifi$ p&emic or epidemic product has 
! mean+ giv5 to su* t]m 9 section       
#cai;,f-#c ( ! ,public ,heal? ,s]vice   
,act 7#db ,u4,s4,c4 #bdg;d-#f;b74